Conversely, SIRT3 overexpression or activation via pharmacological agents can alleviate or even prevent cardiac hypertrophy under pressure overload or treatment with hypertrophic agonists [29,44]. The gene discussed is SIRT3; the disease is cardiac hypertrophy.